McGuire Investment Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-71,301
| Closed | -$1.47M | – | 117 |
|
|
2024
Q3 | $1.47M | Sell |
71,301
-693
| -1% | -$14.2K | 0.21% | 63 |
|
|
2024
Q2 | $1.61M | Sell |
71,994
-4,498
| -6% | -$101K | 0.23% | 59 |
|
|
2024
Q1 | $2.1M | Buy |
76,492
+25,983
| +51% | +$715K | 0.31% | 59 |
|
|
2023
Q4 | $1.54M | Sell |
50,509
-15,475
| -23% | -$472K | 0.26% | 58 |
|
|
2023
Q3 | $2.09M | Buy |
65,984
+2,550
| +4% | +$80.6K | 0.4% | 53 |
|
|
2023
Q2 | $2.59M | Buy |
63,434
+11,021
| +21% | +$449K | 0.48% | 50 |
|
|
2023
Q1 | $1.95M | Buy |
52,413
+17,332
| +49% | +$646K | 0.39% | 51 |
|
|
2022
Q4 | $1.22M | Buy |
+35,081
| New | +$1.22M | 0.26% | 57 |
|